Human monoclonal anti‐D antibodies. I. THEIR PRODUCTION, SEROLOGY, QUANTITATION AND POTENTIAL USE AS BLOOD GROUPING REAGENTS

Belinda M. Kumpel(NHS Blood and Transplant), B. A. Bradley(Southmead Hospital), G. D. Poole(Bristol Institute for Transfusion Sciences)

British Journal of Haematology

January 1, 1989

10.1111/j.1365-2141.1989.tb06285.x

Cited by 93

Related Papers

A prominent lack of IgG1-Fc fucosylation of platelet alloantibodies in pregnancy

|Blood|2013|226

Galactosylation of human IgG monoclonal anti-D produced by EBV-transformed B-lymphoblastoid cell lines is dependent on culture method and affects Fc receptor-mediated functional activity.

|PubMed|1994|107

Mechanism of anti-D-mediated immune suppression – a paradox awaiting resolution?

|Trends in Immunology|2001|103

Efficacy of RhD monoclonal antibodies in clinical trials as replacement therapy for prophylactic anti‐D immunoglobulin: more questions than answers

|Vox Sanguinis|2007|97

Protein-sequence studies on Rh-related polypeptides suggest the presence of at least two groups of proteins which associate in the human red-cell membrane

|Biochemical Journal|1988|86